Is a complete CSBR research report available?

No complete published report is available for Champions Oncology, Inc. (CSBR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Champions Oncology, Inc. (CSBR)

NASDAQ: CSBR · USD

$4.83

+0.02 (+0.4%)· Recorded snapshot

Market cap	67.2M
Revenue (ttm)	60.7M
Net income (ttm)	-1.1M
EPS (ttm)	-$0.08
Shares out	13.9M
Volume	7,359
Beta	0.45

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 60.7M
Net income (ttm): -1.1M
EPS (ttm): -$0.08
Market cap: 67.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Metric	Value
Amount currency	USD
CIK code	0000771856
Company name	Champions Oncology, Inc.
Country	United States
Country code	US
CUSIP number	15870P307
Earnings date	2026-12-14
Earnings time	amc
Employees	214
Employees change	1
Employees growth	0.47%
Enterprise value	$73.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-05-09
Fiscal year end	April
Founded	1985
Industry	Biotechnology
IPO date	1986-03-25
Is primary listing	Yes
Is SPAC	No
ISIN number	US15870P3073
Last 10-K release date	2026-07-27
Last earnings date	2026-09-10
Last refreshed	2026-11-04
Last stock split date	2015-08-12
Last stock split type	Reverse
Market cap	$67.2M
Market cap category	Micro-Cap
Next earnings date	2026-12-14
Options	Yes
Price	$4.83
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-11-03
Symbol	CSBR
U.S. state	New Jersey
Website	https://www.championsoncology.com

Metric

Value

Amount currency

USD

CIK code

0000771856

Company name

Champions Oncology, Inc.

Country

United States

Country code

CUSIP number

15870P307

Earnings date

2026-12-14

Earnings time

amc

Employees

214

Employees change

Employees growth

0.47%

Enterprise value

$73.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-07-31

First seen

2026-05-09

Fiscal year end

April

Founded

1985

Industry

Biotechnology

IPO date

1986-03-25

Is primary listing

Yes

Is SPAC

ISIN number

US15870P3073

Last 10-K release date

2026-07-27

Last earnings date

2026-09-10

Last refreshed

2026-11-04

Last stock split date

2015-08-12

Last stock split type

Reverse

Market cap

$67.2M

Market cap category

Micro-Cap

Next earnings date

2026-12-14

Options

Yes

Price

$4.83

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-11-03

Symbol

CSBR

U.S. state

New Jersey

Website

https://www.championsoncology.com

Metric	Value
Earnings yield	-1.7%
EV/EBITDA	183.68x
EV/Sales	1.22x
FCF / EV yield	-8.31%
FCF yield	-9.13%
Forward EV/Sales	1.47x
Forward P/S	1.34x
P/B ratio	17.27x
P/S ratio	1.11x
Price / tangible book value	18.89x
Price/EBITDA ratio	167.23x
Sector forward P/E	23.32x
Sector P/E	49.47x

Metric

Value

Earnings yield

-1.7%

EV/EBITDA

183.68x

EV/Sales

1.22x

FCF / EV yield

-8.31%

FCF yield

-9.13%

Forward EV/Sales

1.47x

Forward P/S

1.34x

P/B ratio

17.27x

P/S ratio

1.11x

Price / tangible book value

18.89x

Price/EBITDA ratio

167.23x

Sector forward P/E

23.32x

Sector P/E

49.47x

Metric	Value
EBIT margin	-1.53%
EBITDA margin	0.66%
Gross margin	49.82%
Operating margin	-1.53%
Pretax margin	-1.47%
Profit margin	-1.87%
Profit per employee	$-5,304
Revenue per employee	$283,467
ROA	-1.82%
ROA (5Y)	-2.58%
ROCE	-6.39%
ROE	-28.38%
ROE (5Y)	-26.09%
ROIC	-12.53%
SBC / revenue	2.96%
Tax / revenue	0.4%

Metric

Value

EBIT margin

-1.53%

EBITDA margin

0.66%

Gross margin

49.82%

Operating margin

-1.53%

Pretax margin

-1.47%

Profit margin

-1.87%

Profit per employee

$-5,304

Revenue per employee

$283,467

ROA

-1.82%

ROA (5Y)

-2.58%

ROCE

-6.39%

ROE

-28.38%

ROE (5Y)

-26.09%

ROIC

-12.53%

SBC / revenue

2.96%

Tax / revenue

0.4%

Metric	Value
EPS growth years	0
Gross profit growth	9.64%
Gross profit growth (Q)	28.3%
Gross profit growth 3Y	10.3%
Gross profit growth 5Y	7.31%
Net income growth quarters	2
Net income growth years	0
Revenue growth	6.65%
Revenue growth (Q)	8.84%
Revenue growth (QoQ)	10.1%
Revenue growth 10Y	17.56%
Revenue growth 3Y	4.81%
Revenue growth 5Y	7.25%
Revenue growth quarters	2
Revenue growth years	2

Metric

Value

EPS growth years

Gross profit growth

9.64%

Gross profit growth (Q)

28.3%

Gross profit growth 3Y

10.3%

Gross profit growth 5Y

7.31%

Net income growth quarters

Net income growth years

Revenue growth

6.65%

Revenue growth (Q)

8.84%

Revenue growth (QoQ)

10.1%

Revenue growth 10Y

17.56%

Revenue growth 3Y

4.81%

Revenue growth 5Y

7.25%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-573,000
Depreciation and amortization	$1.3M
EBIT	$-931,000
EBITDA	$402,000
EPS	$-0.08
FCF per share	$-0.44
Financing cash flow	$146,000
Free cash flow	$-6.1M
Free cash flow minus SBC	$-7.9M
Gross profit	$30.2M
Income taxes	$243,000
Investing cash flow	$-549,000
Net borrowing	$-116,000
Net cash flow	$-6M
Net income	$-1.1M
Operating cash flow minus SBC	$-7.4M
Operating income	$-931,000
Revenue	$60.7M
Stock-based compensation	$1.8M

Metric

Value

Capital expenditures

$-573,000

Depreciation and amortization

$1.3M

EBIT

$-931,000

EBITDA

$402,000

EPS

$-0.08

FCF per share

$-0.44

Financing cash flow

$146,000

Free cash flow

$-6.1M

Free cash flow minus SBC

$-7.9M

Gross profit

$30.2M

Income taxes

$243,000

Investing cash flow

$-549,000

Net borrowing

$-116,000

Net cash flow

$-6M

Net income

$-1.1M

Operating cash flow minus SBC

$-7.4M

Operating income

$-931,000

Revenue

$60.7M

Stock-based compensation

$1.8M

Metric	Value
Altman Z-Score	0.16
Book value per share	$0.28
Debt / EBITDA	5.02
Debt / equity	2.46
Goodwill	$335,000
Long-term assets	$14M
Long-term liabilities	$10.1M
Net cash (debt)	$-6.6M
Net cash / market cap	-9.84%
Net debt / EBITDA	16.45
Net debt / equity	1.48
Piotroski F-Score	2
Property, plant and equipment	$13.5M
Shareholders' equity	$4.5M
Tangible book value	$3.6M
Tangible book value per share	$0.26
Total assets	$33.3M
Total cash	$4.4M
Total debt	$11M
Total liabilities	$28.8M
WACC	5.78%

Metric

Value

Altman Z-Score

0.16

Book value per share

$0.28

Debt / EBITDA

5.02

Debt / equity

2.46

Goodwill

$335,000

Long-term assets

$14M

Long-term liabilities

$10.1M

Net cash (debt)

$-6.6M

Net cash / market cap

-9.84%

Net debt / EBITDA

16.45

Net debt / equity

1.48

Piotroski F-Score

Property, plant and equipment

$13.5M

Shareholders' equity

$4.5M

Tangible book value

$3.6M

Tangible book value per share

$0.26

Total assets

$33.3M

Total cash

$4.4M

Total debt

$11M

Total liabilities

$28.8M

WACC

5.78%

Metric	Value
Asset turnover	1.9
Current assets	$19.3M
Current liabilities	$18.7M
Current ratio	1.03
Net working capital	$-2.9M
Quick ratio	0.96
Working capital	$563,000
Working capital turnover	-108.23

Metric

Value

Asset turnover

1.9

Current assets

$19.3M

Current liabilities

$18.7M

Current ratio

1.03

Net working capital

$-2.9M

Quick ratio

0.96

Working capital

$563,000

Working capital turnover

-108.23

Metric	Value
Buyback yield / dilution	2.42%
Dividend yield	0%
Shareholder yield	2.42%

Metric

Value

Buyback yield / dilution

2.42%

Dividend yield

Shareholder yield

2.42%

Metric	Value
10Y price change	203.77%
10Y return CAGR	11.75%
10Y total return	203.77%
150-day SMA	$5.55
15Y price change	-44.86%
15Y return CAGR	-3.89%
15Y total return	-44.86%
1D price change	0.42%
1M price change	-2.23%
1M total return	-2.23%
1Y price change	-29.39%
1Y return CAGR	-29.4%
1Y total return	-29.39%
20-day SMA	$4.83
200-day SMA	$5.72
20Y price change	2,583.33%
20Y return CAGR	17.88%
20Y total return	2,583.33%
3M price change	-9.89%
3M total return	-9.89%
3Y price change	-12.66%
3Y return CAGR	-4.41%
3Y total return	-12.66%
50-day SMA	$4.95
50-day SMA vs 200-day SMA	50under200
52-week high	$8.31
52-week high date	2025-12-15
52-week low	$4.59
52-week low date	2026-09-16
5Y price change	-52.41%
5Y return CAGR	-13.8%
5Y total return	-52.41%
6M price change	-19.37%
6M total return	-19.37%
All-time high	$33.00
All-time high date	1992-07-24
All-time low	$0.07
All-time low date	2003-02-19
Average true range (ATR)	$0.22
Average volume	8.7K
Beta (1Y)	-0.19
Beta (2Y)	0.26
Beta (5Y)	0.45
Change from 52-week high	-41.88%
Change from 52-week low	5.23%
Change from all-time high	-85.36%
Change from all-time low	6,608.33%
Change from open	-1.63%
Day's gap	2.08%
Dollar volume	$35,544
High price	$5.06
Low price	$4.81
Monthly RSI	41.83
Open price	$4.91
Position in 52-week range	8%
Previous close	$4.81
Price vs 150-day SMA	-12.91%
Price vs 20-day SMA	0.04%
Price vs 200-day SMA	-15.6%
Price vs 50-day SMA	-2.33%
Relative volume	0.85
RSI	47.78
Sharpe ratio	-0.46
Sharpe ratio (3Y)	0.13
Sharpe ratio (5Y)	0.01
Sortino ratio	-0.59
Sortino ratio (3Y)	0.3
Sortino ratio (5Y)	0.11
Volume	7.4K
Weekly RSI	39.41
YTD price change	-30.1%
YTD total return	-30.1%

Metric

Value

10Y price change

203.77%

10Y return CAGR

11.75%

10Y total return

203.77%

150-day SMA

$5.55

15Y price change

-44.86%

15Y return CAGR

-3.89%

15Y total return

-44.86%

1D price change

0.42%

1M price change

-2.23%

1M total return

-2.23%

1Y price change

-29.39%

1Y return CAGR

-29.4%

1Y total return

-29.39%

20-day SMA

$4.83

200-day SMA

$5.72

20Y price change

2,583.33%

20Y return CAGR

17.88%

20Y total return

2,583.33%

3M price change

-9.89%

3M total return

-9.89%

3Y price change

-12.66%

3Y return CAGR

-4.41%

3Y total return

-12.66%

50-day SMA

$4.95

50-day SMA vs 200-day SMA

50under200

52-week high

$8.31

52-week high date

2025-12-15

52-week low

$4.59

52-week low date

2026-09-16

5Y price change

-52.41%

5Y return CAGR

-13.8%

5Y total return

-52.41%

6M price change

-19.37%

6M total return

-19.37%

All-time high

$33.00

All-time high date

1992-07-24

All-time low

$0.07

All-time low date

2003-02-19

Average true range (ATR)

$0.22

Average volume

8.7K

Beta (1Y)

-0.19

Beta (2Y)

0.26

Beta (5Y)

0.45

Change from 52-week high

-41.88%

Change from 52-week low

5.23%

Change from all-time high

-85.36%

Change from all-time low

6,608.33%

Change from open

-1.63%

Day's gap

2.08%

Dollar volume

$35,544

High price

$5.06

Low price

$4.81

Monthly RSI

41.83

Open price

$4.91

Position in 52-week range

Previous close

$4.81

Price vs 150-day SMA

-12.91%

Price vs 20-day SMA

0.04%

Price vs 200-day SMA

-15.6%

Price vs 50-day SMA

-2.33%

Relative volume

0.85

RSI

47.78

Sharpe ratio

-0.46

Sharpe ratio (3Y)

0.13

Sharpe ratio (5Y)

0.01

Sortino ratio

-0.59

Sortino ratio (3Y)

0.3

Sortino ratio (5Y)

0.11

Volume

7.4K

Weekly RSI

39.41

YTD price change

-30.1%

YTD total return

-30.1%

Metric	Value
Float	6M
Float percentage	43.38%
Shares change (QoQ)	-0.11%
Shares change (YoY)	-2.42%
Shares held by insiders	26.91%
Shares held by institutions	12.74%
Shares outstanding	13.9M
Short % of float	1.29%
Short % of shares	0.56%
Short ratio	5.9 days

Metric

Value

Float

Float percentage

43.38%

Shares change (QoQ)

-0.11%

Shares change (YoY)

-2.42%

Shares held by insiders

26.91%

Shares held by institutions

12.74%

Shares outstanding

13.9M

Short % of float

1.29%

Short % of shares

0.56%

Short ratio

5.9 days

Champions Oncology, Inc. (CSBR)

Price

Financial snapshot

Fair-value bridge

Latest news · CSBR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSBR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSBR

Frequently asked questions